New immunotherapy combo eyed for rare eye cancer before surgery
Disease control
Not yet recruiting
This early-stage trial tests whether giving two immunotherapy drugs (nivolumab and ipilimumab) before eye removal surgery is safe and doable for people with high-risk uveal melanoma, a rare eye cancer. About 15 participants will receive the drugs, then have their eye removed. Res…
Phase: PHASE1 • Sponsor: Inge Marie Svane • Aim: Disease control
Last updated Apr 30, 2026 15:52 UTC